WHO ICTRP trial
The Nanoduct study: a new sweat test system tested
NL-OMON31574 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON31574 |
|---|---|
| Public title | The Nanoduct study: a new sweat test system tested |
| Scientific title | The Nanoduct study: a new sweat test system tested - The Nanoduct study |
| Primary sponsor | RIVM |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Cystic Fibrosis mucoviscoidosis;10015674;10003018;10010613;Cystic Fibrosis;mucoviscoidosis |
| Interventions | Nanoduct sweat test and gold standard test (QPIT or Macroduct). ;Conductivity;Cystic Fibrosis;Nanoduct;Sweat test |
| Registration date | Jun 26, 2008 |
| Target size | 330 |
| Secondary IDs | NL20953.000.08 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: